A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
NCT00991705 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2009-10-08
Summary
The purpose of this study is to evaluate the effect of atorvastatin on the pharmacokinetics of fimasartan.
Conditions
- Essential Hypertension
Interventions
- DRUG
- DRUG
-
Fimasartan
Sponsors & Collaborators
-
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
Kyung-Sang Yu, MD · Seoul National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
NCT03338426 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
NCT01956201 ·Status: UNKNOWN ·Phase: PHASE3
-
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
NCT00917579 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
NCT02579356 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-337(2) Drug-drug Interaction Study
NCT02422030 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
NCT03346187 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
NCT01285544 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
NCT01974297 ·Status: UNKNOWN ·Phase: NA
-
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
NCT00150371 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
NCT03438955 ·Status: UNKNOWN ·Phase: PHASE1
-
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
NCT00120055 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
NCT00973986 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
NCT05930028 ·Status: COMPLETED ·Phase: PHASE3
-
CKD-391 Pharmacokinetic Study
NCT02461004 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-391 Pharmacokinetic Study Phase I
NCT02501200 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
NCT00722956 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
NCT01842230 ·Status: COMPLETED ·Phase: PHASE1
-
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
NCT00442845 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT02587416 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
NCT01842256 ·Status: COMPLETED ·Phase: PHASE1
-
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia
NCT04554953 ·Status: COMPLETED
-
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
NCT00990808 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
NCT03433196 ·Status: COMPLETED ·Phase: PHASE3